References
Levine GN, Bates ER, Bittl JA, Brindis RG, Fihn SD, Fleisher LA, Granger CB, Lange RA, Mack MJ, Mauri L, Mehran R, Mukherjee D, Newby LK, O’Gara PT, Sabatine MS, Smith PK, Smith SC (2016) 2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease: a report of the American College of Cardiology/American Heart Association task force on clinical practice guidelines. J Am Coll Cardiol 68:1082–1115
Valgimigli M, Bueno H, Byrne RA, Collet JP, Costa F, Jeppsson A, Jüni P, Kastrati A, Kolh P, Mauri L, Montalescot G, Neumann FJ, Petricevic M, Roffi M, Steg PG, Windecker S, Zamorano JL, Badimon L, Ibanez B, Vranckx P, Pierard L, Van de Werf F, Agewall S, Andreotti F, Barbato E, Bugiardini R, De Bonis M, Galiè N, Lettino M, Piepoli MF, Stabile E, Antman E, Bassand JP, Cuisset T, Gilard M, Iung B, Leclercq C, Aboyans V, Cikirikcioglu M, Gaemperli O, Schwerzmann M, Delgado V, Verheugt F, Fitzsimons D, Lip G, Simpson IA, Storey RF, Hamm CW, Landmesser U, Sechtem U, James S, Knuuti J, Sousa Uva M, Tendera M (2017) ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS. Eur Heart J 39(3):213–260
Ting C, Fanikos C, Fatani N, Buckley L, Fanikos J (2019) Use of direct oral anticoagulants among patients with limited income and resources. J Am Coll Cardiol 73:526–528
Steinberg BA, Gao H, Shrader P, Pieper K, Thomas L, Camm AJ, Ezekowitz MD, Fonarow GC, Gersh BJ, Goldhaber S, Haas S, Hacke W, Kowey PR, Ansell J, Mahaffey KW, Naccarelli G, Reiffel JA, Turpie A, Verheugt F, Piccini JP, Kakkar A, Peterson ED, Fox KAA (2017) International trends in clinical characteristics and oral anticoagulation treatment for patients with atrial fibrillation. Am Heart J 194:132–140
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
John Fanikos has served as a consultant for Boehringer Ingelheim. The remaining authors have nothing to disclose.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Fatani, N., Fanikos, C., Ting, C. et al. Use of P2Y12 inhibitors among Medicaid beneficiaries between 2008 and 2018. J Thromb Thrombolysis 48, 539–541 (2019). https://doi.org/10.1007/s11239-019-01925-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11239-019-01925-7